The effect of live attenuated inactivated influenza vaccine on experimental human pneumococcal carriage study
Catching the flu can sometimes lead to serious secondary chest infections like bacterial pneumonia. Researchers want to find out whether the type of flu vaccine a person receives changes how pneumonia-causing bacteria (pneumococcus) live in the nose. In this trial, healthy adults aged 18 to 50 are split into two groups. One group receives the live nasal flu spray alongside a dummy injection. The other group receives the standard flu jab alongside a dummy nasal spray. Afterwards, researchers introduce a small, safe amount of bacteria into participants' noses. The study team checks for any symptoms and monitors how much bacteria remains in the nose over time. Taking part helps scientists understand whether the nasal flu spray increases the chances of carrying and spreading these bacteria, helping doctors improve future vaccine programmes.
At a glance
What is this study about?
When people get the flu, their natural defences are weakened, which can make them more vulnerable to secondary bacterial infections like pneumonia. Pneumonia is a serious lung illness often caused by a bug called pneumococcus. Many healthy people carry these bacteria harmlessly at the back of their nose and throat without ever becoming unwell. However, changes in the immune system can sometimes allow the bacteria to multiply and cause illness.
Early laboratory studies suggested that the nasal spray flu vaccine, which uses a weakened live virus, might temporarily increase the amount of pneumococcal bacteria living in the nose. If this happens in people, it could potentially raise the risk of chest infections or make it easier to pass the bacteria on to vulnerable family members.
This study compares the nasal spray vaccine directly with the standard flu jab, which uses an inactivated (killed) virus. By placing a small, safe amount of bacteria into the nose of vaccinated volunteers, doctors can carefully measure whether one vaccine causes higher levels of bacteria than the other. The findings will help public health experts ensure that national vaccination programmes remain as safe and effective as possible.
Key takeaways
- The study tests whether nasal flu spray affects pneumonia bacteria in the nose differently than a flu jab.
- Open to healthy adults aged 18 to 50 who have not had a flu vaccine in the last two years.
- All participants receive a genuine flu vaccination as part of the study.
- Volunteers will have a safe, small dose of bacteria placed into their nose and will be closely monitored.
- The results will help doctors improve the safety and design of future vaccination programmes.
Who may be eligible?
This trial is open to healthy men and women aged between 18 and 50 who speak fluent English. This age group is chosen because young, healthy adults have strong immune systems and are at very low risk of becoming ill from the bacteria used in the trial.
You cannot take part if you have received any flu vaccine within the last two years, if you are a regular smoker, or if you have asthma or other ongoing chest problems. You will also be excluded if you are allergic to eggs, penicillin, or other key medications, or if you take regular aspirin or medicines that affect your immune system.
For safety reasons, volunteers must not live or work in close contact with people at high risk of infection, such as children under five, older adults, or people with long-term health conditions. Women who are pregnant or planning a pregnancy cannot join, and reliable contraception must be used during the trial.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged between 18 and 50 years old.
- I speak fluent English.
- I have not had a flu jab or nasal spray in the last 2 years.
- I am a non-smoker and do not have asthma or chest conditions.
- I do not live with young children under five or people with weakened immune systems.
- I do not have an allergy to eggs or penicillin.
What does participation involve?
If you join the study, you will be randomly placed into one of two groups by chance. One group receives the nasal flu spray and a dummy (placebo) injection, while the other receives the standard flu jab and a dummy nasal spray. Later, doctors will drop a small, carefully controlled amount of pneumococcal bacteria into your nose. You will need to attend several clinic visits at the Royal Liverpool University Hospital for check-ups, blood tests, and nasal swabs to monitor how much bacteria remains in your nose. The study team will provide you with a 24-hour contact number and monitor your health closely throughout the study period.
Potential risks and benefits
Locations (1)
- Royal Liverpool University HospitalCity onlyLiverpool, Merseyside, England
Common questions
Will taking part give me severe pneumonia?
It is extremely unlikely. The dose of bacteria used is very small and safe. Researchers have tested this method in over 400 healthy volunteers without a single case of serious infection, and antibiotic treatment is immediately available if needed.
What is a placebo?
A placebo is a harmless dummy treatment, such as a plain saltwater spray or injection. It looks identical to the real vaccine so neither you nor the doctors know which one you received, ensuring fair and accurate test results.
Could I pass the bacteria on to my family?
The risk is very low, but as a safety precaution, people who live or work closely with young children, elderly relatives, or anyone with a weak immune system cannot take part in this study.
Do I have to pay to take part?
No, you do not have to pay anything. Clinical trials in the UK provide all study medications and tests free of charge, and volunteers often receive help with travel expenses.
What happens if I change my mind during the trial?
You are free to leave the study at any time. Withdrawing will not affect your relationship with your doctor or the standard NHS care you receive.
How to find out more
Angela Wright
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.